Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Fresh2 Group Limited American ADR (FRES)

Fresh2 Group Limited American ADR (FRES)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.8500 -0.2701 (-24.11%) 12/23/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 0.8500 unch (unch) -
News & Headlines for Mon, Dec 23rd, 2024
Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing

FRES : 0.8500 (-24.11%)
Fresh2 Group Ltd. Completes Acquisition of SpeedIn INC, a Delivery Service Provider

/PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES) ("Fresh2," the "Company" or "we"), a company with operations in...

FRES : 0.8500 (-24.11%)
Fresh2 Group Ltd. (FRES) Rings the Nasdaq Stock Market Opening Bell, Driving the Online Transformation of the Restaurant Industry

/PRNewswire/ -- Fresh2 (Nasdaq: FRES), the innovative online B2B e-commerce marketplace, proudly showcased its commitment to transforming the restaurant...

FRES : 0.8500 (-24.11%)
Fresh2 Group Ltd. Announces US$4.4 Million Private Placement

/PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: FRES), a company with operations in the United States and China...

FRES : 0.8500 (-24.11%)

Barchart Exclusives

European Commodities: Cocoa Prices Stay Hot Amid Continued Supply Challenges
Here are the European commodity winners and losers over the past week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective